CL
Colgate-Palmolive Company
NYSE · Consumer Defensive · Household & Personal Products · US
$88.77
−1.47%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 21.0B | 20.4B | 20.1B | 19.5B | 18.0B |
| Cost of Revenue | 8.3B | 8.1B | 8.0B | 8.2B | 7.8B |
| Gross Profit | 12.7B | 12.3B | 12.1B | 11.3B | 10.2B |
| Operating Expenses | |||||
| R&D Expense | — | — | 355.0M | 343.0M | 320.0M |
| SG&A Expense | 8.3B | 7.9B | 7.8B | 6.8B | 6.2B |
| General & Admin Expense | 1.3B | — | 5.1B | — | — |
| Selling & Marketing Expense | 674.0M | — | 2.7B | — | — |
| Other Expenses | 116.0M | — | (442.0M) | — | — |
| Total Operating Expenses | 8.4B | 7.9B | 7.7B | 7.1B | 6.6B |
| Cost and Expenses | 16.7B | 16.0B | 15.7B | 15.3B | 14.4B |
| Operating Income (EBIT) | 4.3B | 4.3B | 4.4B | 4.1B | 3.6B |
| Non-Operating | |||||
| Interest Income | 72.0M | 75.0M | 67.0M | 55.0M | 14.0M |
| Interest Expense | 255.0M | 267.0M | 292.0M | 287.0M | 167.0M |
| Net Interest Income | (183.0M) | (192.0M) | (225.0M) | (232.0M) | (153.0M) |
| Other Non-Op Income/Expense | (1.4B) | (1.3B) | (427.0M) | (739.0M) | (925.0M) |
| Non-Operating Income (excl Interest) | 1.1B | 1.0B | 135.0M | 452.0M | 758.0M |
| EBT (Pre-Tax Income) | 2.9B | 3.1B | 4.0B | 3.4B | 2.7B |
| Income Tax Expense | 780.0M | 798.0M | 907.0M | 937.0M | 693.0M |
| Bottom Line | |||||
| Net Income | 2.0B | 2.1B | 2.9B | 2.3B | 1.8B |
| Earnings from Cont. Ops | 2.2B | 2.3B | 3.0B | 2.5B | 2.0B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 2.0B | 2.1B | 2.9B | 2.3B | 1.8B |
| Per Share | |||||
| Basic EPS | $2.54 | $2.64 | $3.53 | $2.78 | $2.13 |
| Diluted EPS | $2.52 | $2.63 | $3.51 | $2.77 | $2.13 |
| Revenue Per Share | $26.42 | $25.20 | $24.58 | $23.52 | $21.48 |
| Shares | |||||
| Basic Shares Outstanding | 796.6M | 808.7M | 817.7M | 827.4M | 836.4M |
| Diluted Shares Outstanding | 805.8M | 811.1M | 822.5M | 829.2M | 838.8M |
| Profitability Metrics | |||||
| EBITDA | 3.8B | 4.0B | 4.9B | 4.2B | 3.4B |
| D&A | 642.0M | 630.0M | 605.0M | 567.0M | 545.0M |
| EBIT | 3.2B | 3.3B | 4.2B | 3.7B | 2.8B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026